IRIS
RESTEGHINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.133
NA - Nord America 1.391
SA - Sud America 429
EU - Europa 264
AF - Africa 42
OC - Oceania 1
Totale 4.260
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.361
US - Stati Uniti d'America 1.321
CN - Cina 369
BR - Brasile 365
VN - Vietnam 191
IT - Italia 76
HK - Hong Kong 57
GB - Regno Unito 47
IN - India 42
DE - Germania 40
CA - Canada 38
AR - Argentina 30
FR - Francia 24
BD - Bangladesh 23
MX - Messico 21
ZA - Sudafrica 16
PL - Polonia 15
ID - Indonesia 13
IQ - Iraq 13
EC - Ecuador 12
PK - Pakistan 11
RU - Federazione Russa 11
JP - Giappone 10
ES - Italia 9
VE - Venezuela 9
SE - Svezia 8
TR - Turchia 8
CO - Colombia 6
KE - Kenya 6
UZ - Uzbekistan 6
IE - Irlanda 5
MA - Marocco 5
NL - Olanda 5
SA - Arabia Saudita 5
UA - Ucraina 5
NP - Nepal 4
DZ - Algeria 3
ET - Etiopia 3
JO - Giordania 3
KZ - Kazakistan 3
OM - Oman 3
PY - Paraguay 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
BB - Barbados 2
EG - Egitto 2
HR - Croazia 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
TN - Tunisia 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
FI - Finlandia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KR - Corea 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
RS - Serbia 1
SI - Slovenia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 4.260
Salva come PNG Salva come JPEG
Città #
Singapore 575
Ashburn 307
San Jose 289
The Dalles 200
Shanghai 146
Beijing 139
Dallas 89
Ho Chi Minh City 64
Hong Kong 51
Hanoi 40
São Paulo 28
Seattle 26
Los Angeles 24
Assago 20
Boardman 19
New York 19
Montreal 18
Brooklyn 17
Naples 15
Rio de Janeiro 14
Santa Clara 14
Warsaw 12
Düsseldorf 11
Frankfurt am Main 11
Haiphong 10
Orem 10
Tokyo 10
Brasília 9
Chennai 9
Johannesburg 9
Mexico City 9
Milan 8
Paris 8
Atlanta 7
Chicago 7
Da Nang 7
London 7
Stockholm 7
Belo Horizonte 6
Nairobi 6
Phoenix 6
San Francisco 6
Tashkent 6
Boston 5
Buffalo 5
Curitiba 5
Manchester 5
Monza 5
Munich 5
Porto Alegre 5
Portsmouth 5
Quito 5
Ribeirão Preto 5
Biên Hòa 4
Buenos Aires 4
Bắc Ninh 4
Campinas 4
Caruaru 4
Cotia 4
Duque de Caxias 4
Guayaquil 4
Poplar 4
Roubaix 4
Salvador 4
Secaucus 4
Toronto 4
Addis Ababa 3
Amman 3
Ankara 3
Baghdad 3
Bengaluru 3
Bologna 3
Camaçari 3
Can Tho 3
Cape Town 3
City of London 3
Conselheiro Lafaiete 3
Denver 3
Dublin 3
Faisalabad 3
Genoa 3
Goiânia 3
Istanbul 3
Jakarta 3
Joinville 3
Lahore 3
Mumbai 3
Natal 3
Nha Trang 3
São José do Rio Preto 3
Tatuí 3
Thái Bình 3
Thái Nguyên 3
Trieste 3
Uberlândia 3
Vĩnh Long 3
Almaty 2
Amsterdam 2
Barretos 2
Belo Jardim 2
Totale 2.495
Salva come PNG Salva come JPEG
Nome #
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients 91
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 77
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 59
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 56
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 55
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 53
Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient 52
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 51
Big Data in Head and Neck Cancer 51
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial 50
Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT) 50
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol 49
A retrospective cohort study of PD-L1 expression in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SUPREME-HN). 49
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers 49
Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting 48
Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients 48
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 48
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 48
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 47
BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure 46
BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment 46
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 45
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up 45
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? 45
An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients? 45
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 45
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer 44
A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era 44
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. 44
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 44
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic (R/M) squamous cell carcinoma of the head and neck (SUPREME-HN) 44
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 43
A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma 43
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 42
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours 42
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients 41
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 41
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 41
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer 41
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area 41
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 41
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 41
Low etiologic fraction for human papillomavirus in larynx squamous cell carcinoma 41
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 40
Transcriptomic and tumor microenvironment landscape of EBV related nasopharyngeal carcinoma in endemic and non-endemic areas 40
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients 40
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN) 40
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 40
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 40
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 39
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 39
Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC). 39
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 39
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities? 38
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: A ready-to-treat target? 38
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents 38
Treatment Options for Recurrent Anterior Skull Base Tumors 38
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy 37
Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract 37
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 37
Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures 37
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 37
Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy 37
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 37
A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer 37
Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression? 36
HEALTHCARE ASSOCIATED INFECTIONS IN HEAD AND NECK CARCINOMA PATIENTS TREATED WITH CHEMOTHERAPY AND/OR RADIOTHERAPY 36
Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies. 36
RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted? 36
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy 36
Druggable molecular targets in skin adnexal malignancies 36
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience 36
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial 36
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 36
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 35
Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients 35
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 35
Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case series 35
Phase II study on lenvatinib (LEN) in recurrent and/or metastatic (R/M) adenoid cystic carcinomas (ACC) of the salivary glands (SG) of the upper aereodigestive tract (NCT02860936) 34
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions 34
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract 33
Prognostic role of PIK3CA and TP53 in human papillomavirus–negative oropharyngeal cancers 33
Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration 33
Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): A retrospective analysis 32
Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience 32
Treatment-associated mortality in head and neck cancer receiving chemotherapy and radiation: Meta-analysis of published trials 32
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go? 32
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients 32
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies 32
Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients 32
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience 32
Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) 32
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities 31
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure 31
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib 30
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials 30
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 30
Site of metastatic disease influences adenoid cystic cancer (ACC) patients' outcome 29
Neoplasie testa collo 29
Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 29
Totale 4.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024372 0 0 0 0 0 0 0 57 52 45 90 128
2024/20251.164 44 5 4 7 7 113 53 67 211 287 182 184
2025/20262.838 515 191 166 227 156 230 941 130 160 122 0 0
Totale 4.374